By stably overexpressing one of the four genes EGFR, HER2, RAF, or MEK in the estrogen receptor (ER)-positive MCF7 breast cancer cell line, Creighton and colleagues established cell lines with hyperactivation of the MAPK pathway [91]. This evidence concerns the gene ESR1 and breast cancer.